December 2024 Content Release Copied

12/19/20242024 ContentContent releasePhysician, Clinical, Admin, Billing

Clinical Profile Documentation

Additions

The Problems > Add Details area is updated with applicable documentation points for the following diagnoses.

CLDN18.2 expression is now available for Gastric and Esophageal Cancers with the following documentation points:

  • >/= 75%
  • <75%
  • Unknown

FGFR1-4 status is now available for Head and Neck and Pancreatic Cancers with the following documentation points:

  • Fusion
  • Mutation
  • Wild type
  • Other non-actionable finding
  • Unknown

FGFR2 status has been updated for Bile Duct Cancers with the following documentation points:

  • Fusion/Rearrangement
  • Wild type
  • Other non-actionable finding
  • Unknown

FGFR3 status has been updated for Bladder Cancer with the following documentation points:

  • Fusion
  • Mutation
  • Wild type
  • Other non-actionable finding
  • Unknown

Germline BRCA1 and BRCA2 status is now available for Breast, Fallopian Tube, Ovarian, Primary Peritoneal, Pancreatic, Prostate, and Uterine Cancers with the following documentation points:

  • Positive
  • Negative
  • Variant of uncertain significance
  • Unknown

Somatic BRCA1 and BRCA2 status is now available for Breast, Fallopian Tube, Ovarian, Primary Peritoneal, Pancreatic, Prostate, and Uterine Cancers with the following documentation points:

  • Positive
  • Negative
  • Variant of uncertain significance
  • Unknown

RET fusion status is now available for Uterine Cancer, Sarcomas with the following documentation points:

  • Positive
  • Negative
  • Unknown
  • Other non-actionable finding

Line of therapy values are now available for Non-Small Cell Lung Cancer to align with treatment intent differentiation for the following documentation points:

  • Initiation of perioperative treatment (neoadjuvant)
  • Continuation of perioperative treatment
  • Initial adjuvant
  • Extended adjuvant

Removals

FGFR2 Gene is no longer available for Bladder Cancer.

Problems

Additions

New items are available for documentation in Problems and appear in the Charge Capture Report (CCR). Additional ICD-10 codes may be displayed to present the surrounding nodes. Please see APPENDIX A for a complete summary of changes.

Lab Analytes & Panels

Additions

  • Adjusted WBC from manual diff
  • Anti-Xa qual interpretation
  • Babesia burgdorferi PCR
  • Babesia mayonii PCR
  • Babesia microti PCR
  • Beta globin gene sequencing interpretation
  • CLL minimal residual disease (MRD) by flow cytometry panel
  • clonoSEQ B-Cell clonality (includes IGHV mutation status for CLL) panel
  • clonoSEQ MRD tracking ctDNA (DLBCL only) panel
  • clonoSEQ MRD tracking panel
  • clonoSEQ T-Cell clonality panel
  • Endomysial ab titer, IgG
  • FoundationOne monitor ctDNA panel
  • Gliadin(DP) IgA, Ab, ELU/mL
  • Gliadin(DP) IgG, Ab, ELU/mL
  • Histoplasma ag, urine interpretation
  • Histoplasma ag, urine result, ng/mL
  • log10 BKV DNA, plasma, log10 IU/mL
  • Natera report
  • NeoGenomics genetics report
  • NeoTYPE(R) DNA & RNA – lung PDL1 with IVFL reflex
  • NeoTYPE(R) DNA & RNA – lung with IVFL reflex
  • Neutralized PTT-LA ratio
  • OnkoSight advanced plasma cell myeloma NGS allele frequencies panel
  • Parvovirus B19 Ab, IgG, OD Ratio
  • Parvovirus B19 Ab, IgM, OD Ratio
  • Prostate NGS fusion panel
  • TCRB tube C
  • Tempus NeXT MRD
  • Tempus xG+, expanded 77-gene germline testing panel
  • Tempus xR (RNA ONLY) panel
  • Tempus xT (DNA only) with matched normal/tumor and normal panel
  • Tempus xT (DNA only) without matched normal or tumor only panel
  • Tempus xT (DNA) & xR (RNA) – solid tumor/normal panel
  • Tempus xT (DNA) & xR (RNA) panel
  • Tick-borne panel by RT-PCR (Non-NY)
  • West Nile virus PCR, CSF

Medications

Additions

  • AK117 invest IV
  • Hydrocortisone Emergency Kit

Updates

Medication Update
TERN-701 invest Oral New form available: 200 mg tablet
IDE196 invest Oral New form available: 100 mg tablet

New alias available: Darovasertib invest
ZW25 invest or JZ598 invest IV Updated names available: ZW25 invest or JZ598 invest IV
CHS-388 invest IV New alias available: Casdozokitug invest
SRK-181 invest IV New alias available: Linavonkibart invest
M1774 invest Oral New alias available: Tuvusertib invest
M4076 invest Oral New alias available: Larteserib invest
STRO-002 invest IV Updated forms available:

  • 100 mg (20 mg/mL) recon soln
  • 100 mg/10 mL (10 mg/mL) solution

New sigs available:

  •  0 mg/kg intravenously once; **Lyophilized Powder for Solution, 100 mg (20 mg/mL reconstituted concentration) ** DO NOT MIX with D5W.
  • 0 mg/kg intravenously once; **Sterile Frozen Liquid Solution, 100 mg/10 mL (10 mg/mL) ** Compatible with NS or D5W.

Regimen Library

Additions

Regimen Name Diagnosis
Anastrozole + Goserelin Q28D Uterine Cancers
Anastrozle + Leuprolide Q28D Uterine Cancers
Atezolizumab SQ + Bevacizumab + Paclitaxel+ Carboplatin Q21D (Cervical) Cervical Cancer
Atezolizumab SQ + Bevacizumab + Paclitaxel+ Cisplatin Q21D (Cervical) Cervical Cancer
Cisplatin D2 + Lomustine D1 + Vincristine D2,8,15 Q42D Brain Tumors
Exemestane + Goserelin Q28D Uterine Cancers
Exemestane + Leuprolide Q28D Uterine Cancers
Gemcitabine 800 mg/m2 D1,8 Q21D Uterine Cancers
Inavolisib + Palbociclib D1-21 + Fulvestrant Q28D Breast Cancer
Letrozole + Goserelin Q28D (Uterine Sarcoma) Uterine Cancers
Letrozole + Leuprolide Q28D (Uterine Sarcoma) Uterine Cancers
Ponesimod Q30D Multiple Sclerosis
Revumenib Q30D (weight 40 kg or greater WITH concomitant strong CYP3A4 inhibitor) Leukemia, Acute Myeloid (AML); Leukemia, Acute Lymphocytic (ALL)
Revumenib Q30D (weight 40 kg or greater WITHOUT concomitant strong CYP3A4 inhibitor) Leukemia, Acute Myeloid (AML); Leukemia, Acute Lymphocytic (ALL)
Tisotumab vedotin-tftv + Pembrolizumab Q21D Cervical Cancer

 

Updates

Regimens for the following diagnoses have been updated based on the Collaborative Care Committee voting. Changes include but are not limited to reference update, drug infusion instruction updates, renaming of regimens, premedication template updates and number of cycles.

  • Fallopian Tube Cancer
  • Leukemia, Chronic Myeloid (CML)
  • Lymphoma, Non-Hodgkin (NHL)
  • Melanoma, Mucosal, Head and Neck
  • Melanoma, Skin
  • Ovarian and Primary Peritoneal Cancer
  • Thyroid Cancer
  • Uterine Cancer

Renames

Previous Name New Name
Lenvatinib Q30D (Thyroid) Lenvatinib Q30D (Thyroid, Uterine)

Billing and HCPCS

Additions

The January 2025 updates include new HCPCS Level II codes to separately identify products approved under the 505(b)(2) New Drug Application (NDA) or the Biologics License Applications (BLA) pathways after October 2003 and not rated as therapeutically equivalent to a reference listed product in an existing code. A complete application summary and coding link can be found here.

Please visit CMS’s website for a complete list of January 2025 HCPCS Quarterly update. The following products have not been released per First Databank (FDB):

  • J9292 – Pemetrexed (Avyxa) (NDC: 8383113101, 8383113201)
  • Q5139 – Eculizumab-aeeb (Bkemv)
  • Q9996 – Ustekinumab-ttwe (Pyzchiva), subcutaneous
  • Q9997 – Ustekinumab-ttwe (Pyzchiva), intravenous
  • Q9998 – Ustekinumab-aekn (Selarsdi)

Updates

Effective October 1, 2024, CMS updated the HCPCS codes for the following products prior to the HCPCS code deactivation. The CMS pricing files has not yet been updated to reflect these changes:

  • Bendamustine hydrochloride (Apotex) from J9058 to J9036
  • Bendamustine hydrochloride (Baxter) from J9059 to J9036
  • Paclitaxel protein-bound particles (American Regent) from J9259 to J9264

Appendix A

Problem & Codes Summary

Additions

For medications listed below that include a brand name, please refer to the NDC – HCPCS crosswalk table within the release notes for specific dispensable/NDC association.

Medications HCPCS Codes
Bortezomib (Boruzu) J9999 per 2.5 mg
COVID vaccine (Moderna) 91322 per 0.5 mL
Cyclophosphamide (Baxter) J9999 per:

  • 40 mg
  • 200 mg
Dronabinol (Syndros) J3490 per 5 mg
Ensifentrine J3490 per:

  • 3 mg
  • 2.5 mL
 

Inavolisib Oral

 J9999 per

  • 3 mg
  • 9 mg
Lebrikizumab-lbkz Subcutaneous J3590 per 250 mg
Lebrikizumab-lbkz Subcutaneous Pen Injector J3590 per 250 mg
Marstacimab-hncq Subcutaneous Pen Injector J3590 per 150 mg
Mycophenolate mofetil (Myhibbin) J3490 per 200 mg
Nafcillin sodium J3490 per 2 gram
Obecabtagene autoleucel (Aucatzyl) J9999 per 100 c 10e6 CARpos viable T cells
Paliperidone (Erzofri) J3490 per:

  • 39 mg
  • 78 mg
  • 117 mg
  • 156 mg
  • 234 mg
  • 351 mg
Trastuzumab-strf (Hercessi) J9999 per:

  • 150 mg
  • 420 mg
 

Vadadustat (non-ESRD)

 J3490 per:

  • 150 mg
  • 300 mg

Updates

The following codes will be effective January 1, 2025.

Medications HCPCS Codes
Adalimumab J0139 per:

  • 1 mg
  • 1 dose pk
Adalimumab-aacf (Idacio) Q5144 per:

  • 1 mg
  • 1 starter pk
Adalimumab-aaty Q5141 per 1 mg
Adalimumab-adbm Q5143 per:

  • 1 mg
  • 1 dose pk
Adalimumab-afzb (Abrilada) Q5145 per:

  • 1 mg
  • 1 dose pk
Adalimumab-fkjp Q5140 per 1 mg
Adalimumab-ryvk Q5142 per:

  • 1 mg
  • 1 dose pk
Bupivacaine liposome J0666 per:

  • 1 mg
  • 0.075 mL
Crovalimab-akkz J1307 per 10 mg
Cyclophosphamide (Baxter) J9076 per 5 mg
Dronabinol (Syndros) Q0155 per 0.1 mg
Ensifentrine J7601 per:

  • 3 mg
  • 2.5 mL
Exagamglogene autotemcel J3392 per treatment
Fidanacogene elaparvovec-dzkt (Beqvez) J1414 per therapeutic dose
Imetelstat J0870 per 1mg
Immune globulin (Alyglo) J1552 per 500mg
Mycophenolate mofetil (Myhibbin) J7514 per 100 mg
Nafcillin sodium J2290 per

  • 20 mg
  • 0.02 gram
Nogapendekin alfa inbakicept-pmln J9028 per 1 mcg
Pantoprazole sodium in sodium chloride (Baxter) J2472 per 40 mg
Pegulicianine A9615 per 1 mg
Romiplostim J2802 per 1 mcg
Tarlatamab-dlle J9026 per 1 mg
Trastuzumab-strf (Hercessi) Q5146 per 1 mg

Removals

The following codes will be discontinued on December 31, 2024.

Medications HCPCS Codes
Adalimumab J0135 per 20 mg
Adalimumab-aacf (Idacio) Q5131 per 20 mg
Adalimumab-afzb (Abrilada) Q5132 per 10 mg
Bendamustine hydrochloride (Apotex) J9058 per 1 mg
Bendamustine hydrochloride (Baxter) J9059 per 1 mg
Buprenorphine implant J0570 per 74.2 mg
Paclitaxel protein-bound particles (American Regent) J9259 per 1 mg
Romiplostim J2796 per 10 mg

NDC – HCPCS Crosswalk

Additions

The CMS ASP pricing can be found here.

Medication (Brand) HCPCS Code NDC
Bortezomib (Boruzu) J9999 per 2.5 mg 70121248401
Cyclophosphamide (Baxter) J9999

  • 40 mg
  • 200 mg
 00338977701
Mycophenolate mofetil (Myhibbin) J3490 per 200mg 24338001801
Paliperidone (Erzofri) J3490 per:

  • 39 mg
  • 78 mg
  • 117 mg
  • 156 mg
  • 234 mg
  • 351 mg
 72526010511
72526010611
72526010711
72526010811
72526010911
72526011011

Updates

The following HCPCS codes and NDCs will be effective January 1, 2025.

Medication (Brand) HCPCS Code NDC
Cyclophosphamide (Baxter) J9076 per 5 mg 00338977701
Mycophenolate mofetil (Myhibbin) J7514 per 100 mg 24338001801
Pantoprazole IV (Baxter) J2472 per 40 mg 00338964812
00338964401
00338964801
00338964624
00338964601

Professional Services

Additions

The following codes and short descriptions will be effective January 1, 2025.

Code Description
E1803 Adjust elbow extension dev
E1804 Adjust elbow flexion dev
E1807 Adjust wrist extension dev
E1808 Adjust wrist flexion device
E1813 Adjust knee extension device
E1814 Adjust knee flexion device
E1822 Adjust ankle extension dev
E1823 Adjust ankle flexion device
E1826 Adjust finger extension dev
E1827 Adjust finger flexion device
E1828 Adjust toe extension device
E1829 Adjust toe flexion device
G0532 Take home supp nasal spray
G0533 Buprenorphone inj weekly
G0534 Coordinated care/or referral
G0535 Pt navigat svs direct/ref
G0536 Peer recover support svs
G0537 Risk ascvd tst once pr 12 mo
G0538 Ascvd rsk mng clin stf pr mo
G0539 Initial care training 30 m
G0540 Train for caregiver add 15
G0541 No pt prsnt train initial 30
G0542 No pt prsnt train add 15
G0543 Group train w/o patient
G0544 Post d/c phone follow up
G0545 Inherent visit to inpt
G0546 Phone/internet ehr assess
G0547 Phone/internet svs 11-20 m
G0548 Phone/inter svs 21-30 m
G0549 Phone/inter for treat>31m
G0550 Phone/inter for dx/treat >5m
G0551 Phn/intr svs fr dx treat 30m
G0552 Supply of digital device
G0553 Monthly tx for dmht 20mins
G0554 Add 20 m of monthly tx
G0555 Replacement pt electronic sys
G0556 Adv prim care mgmt lvl 1
G0557 Adv prim care mgmt lvl 2
G0558 Adv prim care mgmt lvl 3
G0559 Unrelat prac follow up visit
G0560 Safety plan interven
G0561 Temp tube delivery, unil
G0562 Complex simulation w/pet-ct
G0563 Sbrt w/positron emission del
G0564 365 d implant glucose sensor
G0565 Rem/ins glu snsr 365 dif sit
H0052 Mmip mental health and care
H0053 Ht mental health and care
M1371 Mst rec gsa<7
M1372 Mst rec gsa >=7 and<8
M1373 Mst rec gsa >=8 and <=9
M1374 Ra dx enc 90 days dur per pd
M1375 Ra dx enc 90 days dur per pd
M1376 Ra dx enc 90 days dur per pd
M1377 Fu colscop 10 yr doc w/ disc
M1378 Med rsn no 10 yr fu colscope
M1379 10 yr fu no rec rsn not giv
M1380 2 rx in perf pd any com meds
M1381 Pt sec strk wthin 5 days
M1382 Enc dur perf pd pos 11
M1383 Acute pvd
M1384 Pt died dur perf pd
M1385 Pt rsn not seen 2nd pam
M1386 Exc sx melmn or mlnm is
M1387 Pt died dur perf pd
M1388 Pt doc exm rec melmn
M1390 Pt no doc exm for rec
M1391 All pt dx w/ rec mlnm
M1392 Pt rsn no exm or lst to fu
M1393 Pr no dx rec mlnm
M1394 Stg i-iii br ca
M1395 Init chemo w/def dur ec grp
M1396 Pt ther clin trial
M1397 Pt w/ recur/prog
M1398 Bslne and fu promis doc
M1399 Pt lve prac
M1400 Pt died dur perf pd
M1401 Stg i-iii br ca
M1402 Init chemo w/def dur ec grp
M1403 Bslne and fu promis doc
M1404 Pt ther clin trial
M1405 Pt w/ recur/prog
M1406 Pt lve prac
M1407 Pt died dur perf pd
M1408 Gmln brca bef dx ca
M1409 Recd gmln brca1/brca2 couns
M1410 No gmln brca1/brca2 couns
M1411 1st ln ici no chemo
M1412 Met nsclc w/ egfr alk oth ab
M1413 Pos pdl1 bef init ici tx
M1414 Med rsn no pdl1 bef 1st ther
M1415 No pos pdl1 bef ici ther
M1416 Pt rec hosp
M1417 Pt up to date cov
M1418 Med rsn not up to date cov
M1419 Pt not up to date cov
M1420 Complete ophthalmologic mvp
M1421 Dermatological care mvp
M1422 Gastroenterology care mvp
M1423 Opt care urologic cnd mvp
M1424 Pulmonology care mvp
M1425 Surgical care mvp
Q0521 Supply fee hiv prep fda appr

Removals

The following codes and short descriptions will be retired on December 31, 2024.

Code Description
G0106 Colon ca screen;barium enema
G0120 Colon ca scrn; barium enema
G0122 Colon ca scrn; barium enema
G1001 Cdsm evicore
G1002 Cdsm medcurrent
G1003 Cdsm medicalis
G1004 Cdsm ndsc
G1007 Cdsm aim
G1008 Cdsm cranberry pk
G1010 Cdsm stanson
G1011 Cdsm qualified nos
G1012 Cdsm agilemd
G1013 Cdsm evidencecare
G1014 Cdsm inveniqa
G1015 Cdsm reliant
G1016 Cdsm speed of care
G1017 Cdsm healthhelp
G1018 Cdsm infinx
G1019 Cdsm logicnets
G1020 Cdsm curbside
G1021 Cdsm ehealthline
G1022 Cdsm intermountain
G1023 Cdsm persivia
G1024 Cdsm radrite
G2012 Brief check in by md/qhp
G2070 Med assist tx implant
G2071 Med tx remove implant
G2072 Med tx insert/remove imp
G8482 Flu immunize order/admin
G8483 Flu imm no admin doc rea
G8484 Flu immunize no admin
G8965 Csit perf on low chd rsk
G8966 Csit perf sx or high chd rsk
G9402 Recd f/u w/in 30d disch
G9403 Doc reas no 30 day f/u
G9404 No 30 day f/u
G9405 Recd f/u w/in 7d dc
G9406 Doc reas no 7d f/u
G9407 No 7d f/u
G9458 Tob user recd cess interv
G9459 Tob non-user
G9460 No tob assess or cess inter
G9707 Pt had hosp dur msmt per
G9751 Pt died w/in 24 mos rpt time
G9760 Pt w/hosp anytime msmt per
G9892 Doc pt rsn no dil mac exam
G9893 No mac exam
G9919 Scrn nd pos nd prov of rec
G9920 Scrning perf and negative
G9921 No or part scrn nd rng or os
G9974 Mac exam perf
G9975 Doc med rsn no dil mac exam
G9990 No pneum vax admin 19+
G9991 Pneum vax admin 19+
M0003 Opt care episod neuro mvp
M1154 Hospc serv dur meas pd
M1155 Pt anphx due to pneum
M1219 Anphx due to vax
M1264 Pts 75+ dialysis dt
Q0516 Supply fee hiv prep oral 30
Q0517 Supply fee hiv prep oral 60
Q0518 Supply fee hiv prep oral 90
Q0519 Supply fee hiv prep inj 30
Q0520 Supply fee hiv prep inj 60

Current Procedural Terminology (CPT)

Additions

The following CPT codes and descriptions are effective January 1, 2025.

CPT Code Description
15011 HRV SKIN FOR SKIN CELL SSP AGRFT 1ST 25 SQ CM/<
15012 HRV SKIN FOR SKIN CELL SSP AGRFT EA ADDL 25 SQCM
15013 PREPARATION SKIN CELL SSP AGRFT 1ST 25 SQ CM/<
15014 PREPARATION SKIN CELL SSP AGRFT EA ADDL 25 SQ CM
15015 APPL SKIN CELL SSP AGRFT T/A/L 1ST 480 SQ CM/<
15016 APPL SKIN CELL SSP AGRFT T/A/L EA ADDL 480 SQ CM
15017 APPL SKN CLL SSP AGRFT F/S/N/H/F/G/M/DGT 1ST 480
15018 APPL SKN CLL SSP AGRFT F/S/N/H/F/G/M/DGT EA ADDL
25448 ARTHRP INTERCARPAL/CARP/MTCRPL JT SUSPENSION
38225 CAR-T THERAPY HRVG BLD-DRV T LYMPHCYT PR DAY
38226 CAR-T THERAPY PREPJ BLD-DRV T LYMPHCYT F/TRNS
38227 CAR-T THERAPY RECEIPT & PREPJ CAR-T CELLS F/ADMN
38228 CAR-T THERAPY AUTOL CAR-T CELL ADMINISTRATION
49186 OPEN EXC/DSTRJ INTRA-ABDL TUMOR/CST 5 CM OR LESS
49187 OPEN EXC/DSTRJ INTRA-ABDL TUMOR/CST 5.1-10 CM
49188 OPEN EXC/DSTRJ INTRA-ABDL TUMOR/CST 10.1-20 CM
49189 OPEN EXC/DSTRJ INTRA-ABDL TUMOR/CST 20.1-30 CM
49190 OPEN EXC/DSTRJ INTRA-ABDL TUMOR/CYST >30 CM
51721 INSJ TRURL ABLTJ TRNSDCR DLVR THRM US PRST8 TISS
53865 CYSTO INSJ TEMP DEV ISCHMC RMDLG BLDR NECK&PRST8
53866 CATHJ RMVL TEMP DEV ISCHMC RMDLG BLDR NECK&PRST8
55881 ABLATION TRANSURETHRAL PRST8 TISSUE W/THERMAL US
55882 ABLT TRURL PRST8 TIS THRM US INS TRURL US TRNSDC
60660 ABLTJ 1/+THYROID NODULE 1 LOBE/ISTHMUS PERQ RF
60661 ABLTJ 1/+THYR NDUL ADDL LOBE PERQ RADIOFREQUENCY
61715 MRGFUS STEREOTACTIC ABLATION TARGET INTRACRANIAL
64466 THORACIC FASCIAL PLANE BLOCK UNI INJECTION
64467 THORACIC FASCIAL PLANE BLOCK UNI CONT INFUSION
64468 THORACIC FASCIAL PLANE BLOCK BI INJECTION
64469 THORACIC FASCIAL PLANE BLOCK BI CONT INFUSION
64473 LOWER XTR FASCIAL PLANE BLOCK UNI INJECTION
64474 LOWER XTR FASCIAL PLANE BLOCK UNI CONT INFUSION
66683 IMPLTJ IRIS PROSTHESIS W/SUTR FIXJ&RPR/RMVL IRIS
76014 MR SAFETY IMPLANT&/FB ASSMT CLIN STAF 1ST 15 MIN
76015 MR SAFETY IMPLANT&/FB ASSMT CLIN STAFF EA ADD 30
76016 MR SAFETY DETERMINATION PHYSICIAN/OTHER QHP
76017 MR SAFETY MED PHYSICS XM CUSTOMIZATION PLNG&MNTR
76018 MR SAFETY IMPLT ELECTRONICS PREPJ SUPVJ PHYS/QHP
76019 MR SAFETY IMPLANT POS&/IMMOBLJ SUPVJ PHYS/QHP
81195 CYTOG GEN-WIDE ALYS HEM MAL STRUX VRNT&CNV OGM
81515 NFCT DS BV&VAGINITIS RTPCR AMP DNA MARKERS
81558 TRNSPLJ REJ KDN MRNA GENE XPRSN PRFLG QPCR 139
82233 BETA-AMYLOID 1-40 (ABETA 40)
82234 BETA-AMYLOID 1-42 (ABETA 42)
83884 ASSAY NEUROFILAMENT LIGHT CHAIN
84393 TAU PHOSPHORYLATED EACH
84394 TOTAL TAU (TTAU)
86581 STRPTCS PNEUM ANTIBODY IGG SEROTYPES MLT IA QUAN
87513 IADNA H PYLORI CLARITHROMYCIN RESIST AMP PRB TQ
87564 IADNA MTB RIFAMPIN RESISTANCE AMP PRB TQ
87594 IADNA PNEUMOCYSTIS JIROVECII AMPLIFIED PROBE TQ
87626 IADNA HPV SEP RPRT HI-RSK TYP&HI-RSK POOLD RSLTS
92137 CPTRIZD OPH DX IMG PST SGM UNI/BI RTA OCT ANGRPH
93896 VASOREACTIVITY STUDY W/TCD ICR ARTERIES COMPLETE
93897 EMBOLI DETCJ W/O IV MBUBB NJX TCD ICR ART COMPL
93898 VEN-ARTL SHNT DETC IV MBUB NJX TCD ICR ART COMPL
96041 MED GENETICS&GENETIC COUNSELING SVCS EACH 30 MIN
98000 SYNCHRONOUS AUDIO-VIDEO VISIT NEW SF MDM 15 MIN
98001 SYNCHRONOUS AUDIO-VIDEO VISIT NEW LOW MDM 30 MIN
98002 SYNCHRONOUS AUDIO-VIDEO VISIT NEW MOD MDM 45 MIN
98003 SYNCHRONOUS AUDIO-VIDEO VST NEW HIGH MDM 60 MIN
98004 SYNCHRONOUS AUDIO-VIDEO VISIT EST SF MDM 10 MIN
98005 SYNCHRONOUS AUDIO-VIDEO VISIT EST LOW MDM 20 MIN
98006 SYNCHRONOUS AUDIO-VIDEO VISIT EST MOD MDM 30 MIN
98007 SYNCHRONOUS AUDIO-VIDEO VST EST HIGH MDM 40 MIN
98008 SYNCHRONOUS AUDIO-ONLY VISIT NEW SF MDM 15 MIN
98009 SYNCHRONOUS AUDIO-ONLY VISIT NEW LOW MDM 30 MIN
98010 SYNCHRONOUS AUDIO-ONLY VISIT NEW MOD MDM 45 MIN
98011 SYNCHRONOUS AUDIO-ONLY VISIT NEW HIGH MDM 60 MIN
98012 SYNCHRONOUS AUDIO-ONLY VISIT EST SF MDM 10 MIN
98013 SYNCHRONOUS AUDIO-ONLY VISIT EST LOW MDM 20 MIN
98014 SYNCHRONOUS AUDIO-ONLY VISIT EST MOD MDM 30 MIN
98015 SYNCHRONOUS AUDIO-ONLY VISIT EST HIGH MDM 40 MIN
98016 BRIEF COMMUNICATION TECH-BSD SVC EST PT 5-10 MIN

 Removals

The following CPT codes and descriptions will be retired on December 31, 2024.

CPT Code Description
0352U NFCT DS BCT VAGINOSIS&VAGINITIS MULT AMP PROBE
0398T MRGFUS STEREOTACTIC ABLATION LESION INTRACRANIAL
0500T IADNA HPV 5+ SEP REPRT HIGH RISK HPV TYPES
0537T CAR-T THERAPY HRVG BLD DRV T LMPHCYT PR DAY
0538T CAR-T THERAPY PREPJ BLD DRV T LMPHCYT F/TRNS
0539T CAR-T THERAPY RECEIPT & PREP CAR-T CELLS F/ADMN
0540T CAR-T THERAPY AUTOLOGOUS CELL ADMINISTRATION
0553T PERQ TCAT PLMT ILIAC ARVEN ANASTOMOSIS IMPLANT
0564T ONC CHEMO RX CYTOTOXICITY ASSAY CSC MIN 14 DRUGS
0567T PERM FLP TUB OCCLS W/IMPLANT TRANSCRV APPROACH
0568T INTRO MIX SALINE&AIR F/SSG CONF OCCLS FLP TUBE
0616T INSJ IRIS PROSTH W/SUTURE FIXATION&RPR/RMVL IRIS
0617T INSJ IRIS PROSTH RMVL CRYSTLN LENS &INSJ IO LENS
0618T INSJ IRIS PROSTH SECONDARY IO LENS PLMT/EXCHANGE
15819 CERVICOPLASTY
21632 RADICAL RESECTION STERNUM W/MEDSTNL LMPHADEC
33471 VALVOTOMY PULM VALVE CLSD HEART VIA PULM ARTERY
33737 ATRIAL SEPTECT/SEPTOST OPN HRT W/INFL OCCLUSION
33813 OBLTRJ AORTOPULMONARY SEPTAL DEFECT W/O BYPASS
47802 U-TUBE HEPATICOENTEROSTOMY
49203 EXCISION/DESTRUCTION OPEN ABDOMINAL TUMOR 5 CM/<
49204 EXC/DESTRUCTION OPEN ABDMNL TUMORS 5.1-10.0 CM
49205 EXC/DESTRUCTION OPEN ABDOMINAL TUMORS >10.0 CM
50135 PYELOTOMY COMPLICATED
51030 CSTOTOMY/CSTOST CRYOSURG DSTRJ INTRAVESICAL LES
54438 REPLANTATION PENIS COMP AMPUTATION W/URETH REP
58957 RESECJ RECUR OVARIAN/TUBAL/PERITONEAL MALIGNANCY
81433 HEREDITARY BRST CA-RELATED DUP/DEL ANALYSIS
81436 HEREDITARY COLON CA DSRDRS DUP/DEL ANALYS 5 GEN
81438 HEREDTRY NURONDCRN TUM DSRDRS DUP/DEL ANALYSIS
86327 IMMUNOELECTROPHORESIS CROSSED
86490 SKIN TEST COCCIDIOIDOMYCOSIS
88388 MACR EXM DISS&PRP NONMICR IMPRNT/CONSLT/FRZ SE
90630 INFLUENZA VACC IIV4 SPLIT VIRUS PRSRV FREE ID
90654 INFLUENZA VACC IIV3 SPLIT VIRUS PRSRV FREE ID
93890 TRANSCRANIAL DOPPLER INTRACRAN ART VASOREAC STDY
96003 DYN FINE WIRE EMG WALKG/FUNCJAL ACTV 1 MUSC
96040 MEDICAL GENETICS COUNSELING EACH 30 MINUTES
99441 PHYS/QHP TELEPHONE EVALUATION 5-10 MIN
99442 PHYS/QHP TELEPHONE EVALUATION 11-20 MIN
99443 PHYS/QHP TELEPHONE EVALUATION 21-30 MIN